Top Markets
#1 PulseChain PulseChain +43.68%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.51%
#3 Bitcoin SV Bitcoin SV +4.90%
#4 Fake World Assets Fake World Assets +4.35%
#5 eCash eCash +3.82%
#6 Shuffle Shuffle +3.57%
#7 Magma Finance Magma Finance +3.00%
#8 HOME HOME +2.48%
#9 AI XOVIA AI XOVIA +2.28%
#10 Morpho Morpho +2.27%
Coin of the day
PulseChain PulseChain
設定
言語
日本
通貨
USD
テーマ
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
株式のランク #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
株価
$1.05
最終同期: 2026-08-19
時価総額
$25.12M
変化（1日）
0.00%
変化（1年）
-86.33%
国
US
取引 Actuate Therapeutics Inc (ACTU)

カテゴリー

Healthcare
Actuate Therapeutics Inc（ACTU）の配当利回りの履歴
Actuate Therapeutics Inc（銘柄コード: ACTU）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Actuate Therapeutics Inc（ACTU）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH